"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM617581","Prostate cancer primary tumor PG8","GSM617581","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG8","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617581/GSM617581.CEL.gz","22283"
"GSM617582","Prostate cancer primary tumor PG12","GSM617582","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG12","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617582/GSM617582.CEL.gz","22283"
"GSM617583","Prostate cancer primary tumor PG13","GSM617583","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG13","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617583/GSM617583.CEL.gz","22283"
"GSM617584","Prostate cancer primary tumor PG15","GSM617584","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG15","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617584/GSM617584.CEL.gz","22283"
"GSM617585","Prostate cancer primary tumor PG37","GSM617585","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG37","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617585/GSM617585.CEL.gz","22283"
"GSM617586","Prostate cancer primary tumor PG41","GSM617586","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG41","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617586/GSM617586.CEL.gz","22283"
"GSM617587","Prostate cancer primary tumor PG42","GSM617587","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG42","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617587/GSM617587.CEL.gz","22283"
"GSM617588","Prostate cancer primary tumor PG45","GSM617588","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG 45","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617588/GSM617588.CEL.gz","22283"
"GSM617589","Prostate cancer primary tumor PG46","GSM617589","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG46","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617589/GSM617589.CEL.gz","22283"
"GSM617590","Prostate cancer primary tumor PG50","GSM617590","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG50","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617590/GSM617590.CEL.gz","22283"
"GSM617591","Prostate cancer primary tumor PG52","GSM617591","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG52","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617591/GSM617591.CEL.gz","22283"
"GSM617592","Prostate cancer primary tumor PG53","GSM617592","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PG53","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617592/GSM617592.CEL.gz","22283"
"GSM617593","Prostate cancer primary tumor PR1","GSM617593","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR1","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617593/GSM617593.CEL.gz","22283"
"GSM617594","Prostate cancer primary tumor PR10","GSM617594","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR10","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617594/GSM617594.CEL.gz","22283"
"GSM617595","Prostate cancer primary tumor PR11","GSM617595","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR11","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617595/GSM617595.CEL.gz","22283"
"GSM617596","Prostate cancer primary tumor PR12","GSM617596","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR12","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617596/GSM617596.CEL.gz","22283"
"GSM617597","Prostate cancer primary tumor PR13","GSM617597","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR13","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617597/GSM617597.CEL.gz","22283"
"GSM617598","Prostate cancer primary tumor PR14","GSM617598","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR14","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617598/GSM617598.CEL.gz","22283"
"GSM617599","Prostate cancer primary tumor PR15","GSM617599","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR15","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617599/GSM617599.CEL.gz","22283"
"GSM617600","Prostate cancer primary tumor PR16","GSM617600","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR16","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617600/GSM617600.CEL.gz","22283"
"GSM617601","Prostate cancer primary tumor PR17","GSM617601","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR17","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617601/GSM617601.CEL.gz","22283"
"GSM617602","Prostate cancer primary tumor PR18","GSM617602","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR18","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617602/GSM617602.CEL.gz","22283"
"GSM617603","Prostate cancer primary tumor PR19","GSM617603","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR19","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617603/GSM617603.CEL.gz","22283"
"GSM617604","Prostate cancer primary tumor PR2","GSM617604","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR2","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617604/GSM617604.CEL.gz","22283"
"GSM617605","Prostate cancer primary tumor PR20","GSM617605","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR20","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617605/GSM617605.CEL.gz","22283"
"GSM617606","Prostate cancer primary tumor PR21","GSM617606","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR21","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617606/GSM617606.CEL.gz","22283"
"GSM617607","Prostate cancer primary tumor PR22","GSM617607","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR22","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617607/GSM617607.CEL.gz","22283"
"GSM617608","Prostate cancer primary tumor PR24","GSM617608","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR24","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617608/GSM617608.CEL.gz","22283"
"GSM617609","Prostate cancer primary tumor PR25","GSM617609","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR25","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617609/GSM617609.CEL.gz","22283"
"GSM617610","Prostate cancer primary tumor PR26","GSM617610","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR26","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617610/GSM617610.CEL.gz","22283"
"GSM617611","Prostate cancer primary tumor PR27","GSM617611","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR27","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617611/GSM617611.CEL.gz","22283"
"GSM617612","Prostate cancer primary tumor PR28","GSM617612","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR28","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617612/GSM617612.CEL.gz","22283"
"GSM617613","Prostate cancer primary tumor PR29","GSM617613","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR29","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617613/GSM617613.CEL.gz","22283"
"GSM617614","Prostate cancer primary tumor PR3","GSM617614","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR3","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617614/GSM617614.CEL.gz","22283"
"GSM617615","Prostate cancer primary tumor PR31","GSM617615","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR31","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617615/GSM617615.CEL.gz","22283"
"GSM617616","Prostate cancer primary tumor PR32","GSM617616","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR32","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617616/GSM617616.CEL.gz","22283"
"GSM617617","Prostate cancer primary tumor PR33","GSM617617","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR33","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617617/GSM617617.CEL.gz","22283"
"GSM617618","Prostate cancer primary tumor PR35","GSM617618","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR35","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617618/GSM617618.CEL.gz","22283"
"GSM617619","Prostate cancer primary tumor PR37","GSM617619","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR37","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617619/GSM617619.CEL.gz","22283"
"GSM617620","Prostate cancer primary tumor PR39","GSM617620","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR39","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617620/GSM617620.CEL.gz","22283"
"GSM617621","Prostate cancer primary tumor PR4","GSM617621","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR4","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617621/GSM617621.CEL.gz","22283"
"GSM617622","Prostate cancer primary tumor PR40","GSM617622","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR40","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617622/GSM617622.CEL.gz","22283"
"GSM617623","Prostate cancer primary tumor PR41","GSM617623","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR41","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617623/GSM617623.CEL.gz","22283"
"GSM617624","Prostate cancer primary tumor PR42","GSM617624","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR42","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617624/GSM617624.CEL.gz","22283"
"GSM617625","Prostate cancer primary tumor PR43","GSM617625","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR43","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617625/GSM617625.CEL.gz","22283"
"GSM617626","Prostate cancer primary tumor PR44","GSM617626","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR44","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617626/GSM617626.CEL.gz","22283"
"GSM617627","Prostate cancer primary tumor PR45","GSM617627","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR45","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617627/GSM617627.CEL.gz","22283"
"GSM617628","Prostate cancer primary tumor PR47","GSM617628","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR47","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617628/GSM617628.CEL.gz","22283"
"GSM617629","Prostate cancer primary tumor PR48","GSM617629","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR48","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617629/GSM617629.CEL.gz","22283"
"GSM617630","Prostate cancer primary tumor PR49","GSM617630","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR49","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617630/GSM617630.CEL.gz","22283"
"GSM617631","Prostate cancer primary tumor PR5","GSM617631","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR5","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617631/GSM617631.CEL.gz","22283"
"GSM617632","Prostate cancer primary tumor PR50","GSM617632","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR50","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617632/GSM617632.CEL.gz","22283"
"GSM617633","Prostate cancer primary tumor PR51","GSM617633","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR51","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617633/GSM617633.CEL.gz","22283"
"GSM617634","Prostate cancer primary tumor PR52","GSM617634","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR52","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617634/GSM617634.CEL.gz","22283"
"GSM617635","Prostate cancer primary tumor PR53","GSM617635","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR53","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617635/GSM617635.CEL.gz","22283"
"GSM617636","Prostate cancer primary tumor PR54","GSM617636","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR54","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617636/GSM617636.CEL.gz","22283"
"GSM617637","Prostate cancer primary tumor PR55","GSM617637","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR55","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617637/GSM617637.CEL.gz","22283"
"GSM617638","Prostate cancer primary tumor PR56","GSM617638","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR56","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617638/GSM617638.CEL.gz","22283"
"GSM617639","Prostate cancer primary tumor PR57","GSM617639","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR57","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617639/GSM617639.CEL.gz","22283"
"GSM617640","Prostate cancer primary tumor PR58","GSM617640","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR58","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617640/GSM617640.CEL.gz","22283"
"GSM617641","Prostate cancer primary tumor PR59","GSM617641","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR59","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617641/GSM617641.CEL.gz","22283"
"GSM617642","Prostate cancer primary tumor PR6","GSM617642","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR6","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617642/GSM617642.CEL.gz","22283"
"GSM617643","Prostate cancer primary tumor PR60","GSM617643","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR60","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617643/GSM617643.CEL.gz","22283"
"GSM617644","Prostate cancer primary tumor PR61","GSM617644","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR61","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617644/GSM617644.CEL.gz","22283"
"GSM617645","Prostate cancer primary tumor PR62","GSM617645","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR62","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617645/GSM617645.CEL.gz","22283"
"GSM617646","Prostate cancer primary tumor PR63","GSM617646","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR63","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617646/GSM617646.CEL.gz","22283"
"GSM617647","Prostate cancer primary tumor PR64","GSM617647","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR64","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617647/GSM617647.CEL.gz","22283"
"GSM617648","Prostate cancer primary tumor PR65","GSM617648","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR65","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617648/GSM617648.CEL.gz","22283"
"GSM617649","Prostate cancer primary tumor PR66","GSM617649","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR66","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617649/GSM617649.CEL.gz","22283"
"GSM617650","Prostate cancer primary tumor PR68","GSM617650","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR68","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617650/GSM617650.CEL.gz","22283"
"GSM617651","Prostate cancer primary tumor PR69","GSM617651","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR69","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617651/GSM617651.CEL.gz","22283"
"GSM617652","Prostate cancer primary tumor PR7","GSM617652","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR7","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617652/GSM617652.CEL.gz","22283"
"GSM617653","Prostate cancer primary tumor PR70","GSM617653","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR70","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617653/GSM617653.CEL.gz","22283"
"GSM617654","Prostate cancer primary tumor PR71","GSM617654","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Non-Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR71","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617654/GSM617654.CEL.gz","22283"
"GSM617655","Prostate cancer primary tumor PR72","GSM617655","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR72","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617655/GSM617655.CEL.gz","22283"
"GSM617656","Prostate cancer primary tumor PR73","GSM617656","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR73","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617656/GSM617656.CEL.gz","22283"
"GSM617657","Prostate cancer primary tumor PR74","GSM617657","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR74","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617657/GSM617657.CEL.gz","22283"
"GSM617658","Prostate cancer primary tumor PR8","GSM617658","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR8","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617658/GSM617658.CEL.gz","22283"
"GSM617659","Prostate cancer primary tumor PR9","GSM617659","Public on Nov 05 2010","Nov 04 2010","Nov 04 2010","RNA","1","Human prostate cancer","Homo sapiens","tissue: Prostate cancer primary tumor","recurrence status: Recurrent","total RNA","RNeasy kit","biotin","Biotinylated cRNA was prepared according to standard Affymetrix protocols","9606","Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","PR9","Prostate cancer primary tumor","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","GPL96","Steve,,Goodison","Cancer Research Institute","M. D. Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","32827","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM617nnn/GSM617659/GSM617659.CEL.gz","22283"
